StonvexLoading…
StonvexStonvexStonvexCore line items from MRMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $159.83M | $157.71M | $148.60M | $134.01M |
Operating Income | $-2.82M | $2.61M | $14.38M | $20.37M |
Net Income | $-14.48M | $-12.47M | $-16.03M | $13.47M |
EPS (Diluted) | $-0.04 | $-0.03 | $-0.04 | $0.04 |
Total Assets | $202.56M | $206.99M | $196.12M | $152.20M |
Total Liabilities | $137.83M | $129.44M | $107.21M | $57.17M |
Cash & Equivalents | $8.88M | $7.28M | $14.64M | $9.74M |
Free Cash Flow OCF − CapEx | $6.53M | $-5.17M | $-12.22M | $-4.83M |
Shares Outstanding | 396.91M | 381.48M | 375.13M | 341.47M |